Modern VaccinesAdjuvants Formulation

15-17 May 2013, CHUV, Lausanne, Switzerland

  • Increase font size
  • Default font size
  • Decrease font size

Day One

Final Conference Programme | Wednesday 15th May

08.00 Onwards
Registration

08.55-09.00
Welcome & Opening Remarks
Geert Vanden Bossche (UNIVAC llc., Seattle, Washington, USA)

SESSION 1:
OPENING PLENARY

Moderator: Geert Vanden Bossche (UNIVAC llc., Seattle, Washington, USA)

09.00-09.30
‘An overview of modern vaccines/adjuvants and their potential future development’
Ennio de Gregorio (Novartis Vaccines & Diagnostics, Siena, Italy)

09.30-10.00
‘The rationales and trends for future vaccine adjuvants’
Virgil Schijns (University of Wageningen, Wageningen, The Netherlands)

10.00-10.30
‘Adjuvants: The needs, the knowns and the unknowns’
Martin Friede (WHO, Geneva, Switzerland)

10.30-11.00
Coffee Break & Poster Set-Up

SESSION 2:
PLENARY II

Moderator: Martin Friede (WHO, Geneva, Switzerland)

11.00-11.30
‘Addressing the challenge of access to adjuvants’
Nicolas Collin (University of Lausanne, Epalinges, Switzerland)

11.30-12.00
‘Moving from empiricism and alchemy to rational vaccine design: A badly needed (r)evolution in vaccinology?’
Geert Vanden Bossche (UNIVAC llc., Seattle, Washington, USA)

12.00-12.30
‘Adjuvant properties of polyethyleneimine’
Quentin Sattentau (University of Oxford, Oxford, UK)

12.30-13.00
‘Adjuvanted HIV envelope vaccines: The challenge of eliciting HIV broadly neutralizing antibodies’
Hansi Dean (IAVI, University of Wisconsin, Madison, Wisconsin, USA)

13.00-14.00
Lunch Break & Posters

SESSION 3:
(NANO)PARTICULATES VACCINE ADJUVANTS I

Moderator: Guro Gafvelin (Viscogel AB, Solna, Sweden)

14.00-14.30
‘Nanoparticles as vaccine adjuvants – strategies to enhance immunogenicity’
Gerrit Borchard (University of Geneva, Geneva, Switzerland)

14.30-14.50
‘Polymeric nanoparticle conjugated antigen and CpG adjuvanted enhance Th1 and cytotoxic CD8+ effector and memory cellular responses’
Jeffrey A. Hubbell, Marie Ballester, Sachiko Hirosue, Chiara Nembrini, Evan A. Scott, Eleonora Simeoni, Armando Stano, Melody A. Swartz and Alexandre de Titta (Ecole Polytechnique Federale de Lausanne, Lausanne, Switzerland)

14.50-15.10
‘A balanced Th1/Th2./TH17 immune response to a nanoemulsion-inactivated and formulated whole RSV vaccine and its efficacy against live challenge in mouse and cotton rat animal challenge models’
Ali Fattom (NanoBio Corporation, Ann Arbor, Michigan, USA)

15.10-15.30
‘Matrix-M™ – recent clinical and preclinical experience’
Sofia Magnusson and Linda Stertman (Isconova AB, Uppsala, Sweden)

15.30-16.00
Tea Break & Posters

SESSION 4:
(NANO)PARTICULATES VACCINE ADJUVANTS II

Moderator: Ali Fattom (NanoBio Corporation, Ann Arbor, Michigan, USA)

16.00-16.20
‘Inter-cilayer cross-linked membrane vesicles, new solutions for old problems in malaria’
Adrienne Li, James Moon and Darrell Irvine (Vedantra Pharmaceuticals, Cambridge, Masachusetts, USA)

16.20-16.40
‘Clinical results from a Phase I/II trial with the chitosan based adjuvant ViscoGel’
Guro Gafvelin1,2, Theresa Neimert-Andersson1, Mattias Enoksson1, Jonas Binnmyr2, Joakim Langebäck1, Louise Zettergren1, Anne-Charlotte Hällgren1, Henry Franzén1, Alf Lindberg1, Peter Singer1, Mats Andersson1 and Hans Grönlund2 (Viscogel AB, Solna, Sweden1 and Karolinska Institutet, Stockholm, Sweden2)

16.40-17.00
‘Recombinant lipoimmunogen based intrinsic adjuvant for vaccine design and adjuvantation’
Chih-Hsiang Leng, Shih-Jen Liu, Hsin-Wei Chen, Hsueh-Hung Liu, Yan Kwok, Chang-Ling Lin, Li-Hsiu Lin, Mei-Yu Chen, Jy-Ping Tsai, Li-Sheng Chang, Fang-Feng Chiu, Li-Wei Lai, Wei-Cheng Lian, Chiou-Ying Yang, Shih-Yang Hsieh, Chiung-Yi Huang, Jeremy J.W. Chen and Pele Chong (National Institute of Infectious Diseases and Vaccinology, Miaoli, Taiwan)

17.00-17.20
‘Cationic liposomes as delivery system for a lipooligosaccharide and TbpB based vaccine against group B meningococcal disease’
F. Dalencon, N. Mistretta, B. Guy, Y. Berard, O. Fratantonio, C. Gregoire, A. Lechevallier, P. Lheritier, L. Revet, M. Moreau, J. Haensler and B. Rokbi (Sanofi Pasteur, Marcy l’Etoile, France)

17.20-17.40
‘Emulsified nanoparticles based on amphiphilic bioresorbable polymers and their role in vaccine immunogenicity’
Pele Chong, Chih-wei Lin, Chung-Yi Huang, Chih-Hsiang Leng, Shih-Jen Liu, Hsin-Wei Chen and Ming-Hsi Huang (National Institute of Infectious Diseases and Vaccinology, Miaoli, Taiwan)

17.40-18.00
‘Viruses characterization and quantification using tunable resistive pulse sensing’
Dimitri Aubert (Izon Science Ltd, Oxford, UK)

18.00-19.00
MVAF 2013 Welcome Drinks & Poster Session

 

MVAF 2013 Delegates

Login details will be supplied after you have registered for the event.


MVAF 2013 Sponsors

  • Inovio
  • Izon
  • Retroscreen Virology
  • Immune Design
  • IDRI
  • DNA Vaccine
  • Brenntag
  • Aldevron
  • Immune Solutions
  • Sanofi Pasteur
  • CSL
  • Vironova
  • European Adjuvant Advisory Committee
  • Pfizer
  • Vedantra Pharmaceuticals
  • Intercell
  • Univac
  • Dynavax
  • Wittycell
  • Viscogel
  • Novartis Vaccines
  • Mucosis
  • Pharvat
  • Seppic
  • Vaccine Formulation Laboratory

MVAF 2013 Downloads

MVAF 2013 Leaflet

MVAF 2013 Mailing List

Name
E-mail Address
What is 1+4-2?